News
Immunoglobulin E: Your body makes IgE antibodies when it overreacts to substances that aren't harmful, such as pollen or pet dander. Your doctor will likely measure your IgE levels if you have a ...
The immunoglobulin E (IgE) antibody is a key mediator of allergic responses in food allergies and allergic rhinitis, commonly known as hay fever. In someone with an allergy, ...
Your body creates a protein (you might hear it called an antibody) called immunoglobulin E or IgE to fight allergens. It kicks off an over-the-top reaction to something that should be harmless ...
The initiation of immunoglobulin-E (IgE)-mediated allergic responses requires the binding of IgE antibody to its high-affinity receptor, FcεRI. Crosslinking of FcεRI initiates an intracellular ...
Epsilogen is a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer. IgE’s natural function is to provide immunological defense against certain parasites.
Meanwhile, TigaTx, which has been flying under the radar until now, is contributing TIGA-001 (now renamed EPS 401), an anti-EGFR IgA antibody with studies underway to prepare for human trials in 2026.
Get Instant Summarized Text (Gist) A novel IgE antibody therapy has shown promise in reducing tumor growth in treatment-resistant HER2-expressing breast and ovarian cancers.
LONDON--(BUSINESS WIRE)--Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces that it has commenced a Phase Ib study evaluating ...
By generating anti-HER2 IgE antibodies equivalent to the clinically used IgGs, for the first time we demonstrate that IgEs harness unique mechanisms to reprogramme the immune microenvironment, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results